Subject Companies

 
News Articles for Subject Companies top ^
Data From Part 1 of the Trial Will be Presented at the American Neurological Association Annual Meeting (ANA) ITI-007 is Safe and Well-Tolerated With a Dose-Related Pharmacokinetic Profile in Geriatric Subjects Consistent With Previous Studies NEW YORK, Oct.
Sign-up for Intra-Cellular Therapies Announces Topline Safety Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis (apixaban) by 4-factor prothrombin complex concentrates (PCCs) in healthy subjects.
Sign-up for Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1145602&ProfileId=051205&sourceType=1 CEDAR KNOLLS, NJ --
Sign-up for MYOS Corporation Announces Research Agreement With Human Metabolome Technologies America to Conduct Clinical Metabolomic Studies in Subjects Using Fortetropin(TM) investment picks
2014/10/7
Only 20 percent of manufacturers today rely on objective data to make decisions about process changes.
Sign-up for Ubisense Survey Finds 80 Percent of Manufacturers Rely on Subjective Data to Make Process Changes investment picks
2014/10/6
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G023140-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/3/11G023140/ELS_NS_Logo_2C_RGB-939302954015.jpg http://www.marketwire.com/library/MwGo/2014/10/3/11G023140/Images/Managing_for_Results_Peter_Drucker_hi-res-1328617380692.jpg Leading business management thinker Peter Drucker is author of Managing for Results, which is now available in Elsevier's Legacy Collection.
Sign-up for Elsevier Adds Five New Subject Areas to Legacy eBook Collection investment picks
GAITHERSBURG, Md., Oct.
Sign-up for Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects investment picks
GAITHERSBURG, Md., Nov.
Sign-up for Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026543-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/17/11G026543/Logo1-1448457053.jpg HENDERSON, NV--(Marketwired - November 17, 2014) - Blue Earth, Inc. (NASDAQ: BBLU) an alternative/renewable energy and energy efficiency services company, announced it has signed a letter of agreement that provides the Company the exclusive rights to acquire six projects totaling 273 MW's, that are in various stages of development.
Sign-up for Blue Earth Annouces Letter of Agreement to Purchase 273MW's of Solar and Wind Projects in Mexico Subject to Completion of Due Diligence investment picks
--- Data Published In Nature's Scientific Reports shows gain of 81 milliseconds in processing speed and improvement of 20/20 vision to 20/16 vision, which is typically associated with top athletes in baseball, football, ice-hockey, basketball and tennis ---
Sign-up for New study shows 40% improvement in visual processing speed in young subjects with 20/20 vision, following use of a new technology by GlassesOff, potentially offering superior athletic performance in sports requiring swift reaction time investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Subject Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Study Results  |  Next: Subordinated Debt